loading
X T L Biopharmaceuticals Ltd Adr stock is traded at $1.79, with a volume of 2,278. It is down -3.24% in the last 24 hours and down -14.22% over the past month. XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
See More
Previous Close:
$1.85
Open:
$1.82
24h Volume:
2,278
Relative Volume:
0.06
Market Cap:
$9.32M
Revenue:
-
Net Income/Loss:
$-2.25M
P/E Ratio:
-3.7605
EPS:
-0.476
Net Cash Flow:
-
1W Performance:
+1.99%
1M Performance:
-14.22%
6M Performance:
-33.53%
1Y Performance:
+73.79%
1-Day Range:
Value
$1.71
$1.82
1-Week Range:
Value
$1.71
$1.96
52-Week Range:
Value
$0.76
$4.9897

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
Name
X T L Biopharmaceuticals Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
4
Name
Twitter
@xtlbio
Name
Next Earnings Date
2024-05-24
Name
Latest SEC Filings
Name
XTLB's Discussions on Twitter

Compare XTLB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
XTLB 1.79 9.32M 0 -2.25M 0 -0.476
VRTX 467.17 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.51 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 565.09 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.39 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.56 24.08B 3.30B -501.07M 1.03B 11.54

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

Date Action Analyst Rating Change
May-08-15 Initiated H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Latest News

pulisher
Nov 12, 2024

XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks

Nov 12, 2024
pulisher
Oct 27, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN

Oct 27, 2024
pulisher
Oct 15, 2024

XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks

Oct 15, 2024
pulisher
Aug 14, 2024

XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks

Aug 14, 2024
pulisher
Jul 22, 2024

XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com

Jul 22, 2024
pulisher
Jul 22, 2024

XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes - TipRanks

Jul 22, 2024
pulisher
Jun 19, 2024

A stock that deserves closer examination: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) – US Post News - US Post News

Jun 19, 2024
pulisher
Jun 12, 2024

XTL Biopharmaceuticals Announces Upcoming Shareholder MeetingTipRanks.com - TipRanks

Jun 12, 2024
pulisher
Jun 05, 2024

XTL Biopharmaceuticals acquires AI firm Social Proxy By Investing.com - Investing.com

Jun 05, 2024
pulisher
Jun 05, 2024

XTL Biopharmaceuticals acquires AI firm Social Proxy - Investing.com India

Jun 05, 2024
pulisher
Jun 05, 2024

XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.TipRanks.com - TipRanks

Jun 05, 2024
pulisher
Jun 05, 2024

XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewswire Inc.

Jun 05, 2024
pulisher
May 30, 2024

Market Recap: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB)'s Positive Momentum, Closing at 2.62 – DWinneX - The Dwinnex

May 30, 2024
pulisher
May 14, 2024

XTL Biopharmaceuticals Expands Portfolio Amidst Profitable QuarterTipRanks.com - TipRanks

May 14, 2024
pulisher
Apr 02, 2024

XTL Biopharmaceuticals Regains Nasdaq ComplianceTipRanks.com - TipRanks

Apr 02, 2024
pulisher
Mar 21, 2024

XTL Biopharmaceuticals Convenes Extraordinary General MeetingTipRanks.com - TipRanks

Mar 21, 2024
pulisher
Mar 21, 2024

Enhance Your Investment Strategy with Altman Z-Score Screener By Investing.com - Investing.com India

Mar 21, 2024
pulisher
Mar 20, 2024

XTL Biopharmaceuticals Acquires The Social Proxy - TipRanks

Mar 20, 2024
pulisher
Jan 14, 2021

The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidanc - Benzinga

Jan 14, 2021
pulisher
Dec 18, 2020

The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data - Benzinga

Dec 18, 2020
pulisher
Sep 10, 2020

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial - Benzinga

Sep 10, 2020
pulisher
Mar 19, 2020

The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance

Mar 19, 2020
pulisher
Mar 12, 2020

List of US Companies Releasing Earnings (EPS) Today - FX Leaders

Mar 12, 2020
pulisher
Mar 11, 2020

The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 T - Benzinga

Mar 11, 2020
pulisher
Mar 10, 2020

The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rock - Benzinga

Mar 10, 2020
pulisher
Nov 21, 2019

The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance

Nov 21, 2019
pulisher
Mar 09, 2017

15 Biggest Mid-Day Gainers For ThursdayCuris (NASDAQ:CRIS), Federal Agricultural (NYSE:AGM), Canadian - Benzinga

Mar 09, 2017
pulisher
Feb 17, 2017

Mid-Afternoon Market Update: Monotype Drops On Earnings Miss; LMI Aerospace Shares Spike HigherDeere ( - Benzinga

Feb 17, 2017
pulisher
Jan 04, 2016

Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter - Benzinga

Jan 04, 2016
pulisher
Aug 26, 2015

Morning Market LosersCentury Aluminum (NASDAQ:CENX) - Benzinga

Aug 26, 2015

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):